Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23042-75-3

Post Buying Request

23042-75-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23042-75-3 Usage

Description

N-(2,4-dimethoxyphenyl)acetamide is an organic compound that features a phenyl group with two methoxy substituents at the 2nd and 4th positions, attached to an amide functional group. This chemical structure endows it with specific reactivity and properties that make it useful in various chemical reactions and applications.

Uses

Used in Chemical Synthesis:
N-(2,4-dimethoxyphenyl)acetamide is used as a reactant for the synthesis of regioselective halogenation of aromatic compounds. Its presence in the reaction mixture aids in achieving a specific orientation of the halogen atom on the aromatic ring, which is crucial for the subsequent reactions and the desired product's properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, N-(2,4-dimethoxyphenyl)acetamide may be utilized as an intermediate in the synthesis of various drugs and pharmaceutical compounds. Its unique structure can be further modified to create molecules with specific biological activities, contributing to the development of new medications.
Used in Material Science:
The compound may also find applications in material science, particularly in the development of novel materials with tailored properties. Its ability to participate in specific chemical reactions can lead to the creation of new polymers, coatings, or other materials with improved characteristics.

Check Digit Verification of cas no

The CAS Registry Mumber 23042-75-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,0,4 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23042-75:
(7*2)+(6*3)+(5*0)+(4*4)+(3*2)+(2*7)+(1*5)=73
73 % 10 = 3
So 23042-75-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO3/c1-7(12)11-9-5-4-8(13-2)6-10(9)14-3/h4-6H,1-3H3,(H,11,12)

23042-75-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2,4-dimethoxyphenyl)acetamide

1.2 Other means of identification

Product number -
Other names EINECS 245-394-7

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23042-75-3 SDS

23042-75-3Relevant articles and documents

Evaluation of DIMBOA analogs as antifeedants and antibiotics towards the aphid Sitobion avenae in artificial diets

Escobar, Carlos A.,Sicker, Dieter,Niemeyer, Hermann M.

, p. 1543 - 1554 (1999)

A total of 25 compounds including benzoxazinones, benzoxazolinones, and N-glyoxylamide derivatives were tested as antifeedants and antibiotics towards the aphid Sitobion avenae in diet bioassays. The antifeedant and mortality indexes increased with the presence of electron-donating groups in the 7 position of the benzoxazinone moiety, the replacement of the oxygen atom by sulfur in the heterocyclic ring, the presence of a hemiacetal instead of an acetal at C-2 of the benzoxazine moiety (and hence the possibility of ring opening), and the presence of a hydroxyl group at C-4 of the benzoxazine moiety (hydroxamic acid) instead of a hydrogen atom (lactam). The results support earlier hypotheses on the chemical bases for the mode of action of these compounds.

Isoxazole sulfonamides compound with BRD4 inhibitory activity and preparation method and application thereof

-

Paragraph 0087-0088, (2021/11/19)

The invention provides an isoxazole sulfonamide compound with BRD4 inhibitory activity or a pharmaceutically acceptable salt thereof, and the compound has the structural formula shown in the general formula (I). The invention further provides an application of the compound or a pharmaceutically acceptable salt or the pharmaceutical composition in preparation of a medicament for preventing or treating cancer related to BRD4, wherein the cancer comprises leukemia. The lymphoma, myeloma, lung cancer, prostate cancer, pancreatic cancer, colon cancer, breast cancer, liver cancer, gastric cancer, and the like. The invention provides a novel BRD4 inhibitor, and experiments prove that the novel compound has a 3 - ethyl benzo [d] isoxazole sulfonamide structure and has a good BRD4 protein inhibition effect and an in-vitro tumor cell inhibition effect. The compounds can also effectively inhibit the expression of c-Myc oncogenes.

Structure-Based Discovery and Optimization of Benzo [d] isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)

Zhang, Maofeng,Zhang, Yan,Song, Ming,Xue, Xiaoqian,Wang, Junjian,Wang, Chao,Zhang, Cheng,Li, Chenchang,Xiang, Qiuping,Zou, Lingjiao,Wu, Xishan,Wu, Chun,Dong, Baijun,Xue, Wei,Zhou, Yulai,Chen, Hongwu,Wu, Donghai,Ding, Ke,Xu, Yong

, p. 3037 - 3058 (2018/04/23)

The bromodomain and extra-terminal (BET) family proteins have gained increasing interest as drug targets for treatment of castration-resistant prostate cancer (CRPC). Here, we describe the design, optimization, and evaluation of benzo[d]isoxazole-containing compounds as potent BET bromodomain inhibitors. Cocrystal structures of the representative inhibitors in complex with BRD4(1) provided solid structural basis for compound optimization. The two most potent compounds, 6i (Y06036) and 7m (Y06137), bound to the BRD4(1) bromodomain with Kd values of 82 and 81 nM, respectively. They also exhibited high selectivity over other non-BET subfamily members. The compounds potently inhibited cell growth, colony formation, and the expression of AR, AR regulated genes, and MYC in prostate cancer cell lines. Compounds 6i and 7m also demonstrated therapeutic effects in a C4-2B CRPC xenograft tumor model in mice. These potent and selective BET inhibitors represent a new class of compounds for the development of potential therapeutics against CRPC.

Selective, Catalytic, and Metal-Free Coupling of Electron-Rich Phenols and Anilides Using Molecular Oxygen as Terminal Oxidant

Bering, Luis,Vogt, Melina,Paulussen, Felix M.,Antonchick, Andrey P.

supporting information, p. 4077 - 4080 (2018/07/15)

Selective oxidative homo- and cross-coupling of electron-rich phenols and anilides was developed using nitrosonium tetrafluoroborate as a catalyst. Oxidative coupling of phenols revealed unusual selectivities, which translated into the unprecedented synthesis of inverse Pummerer-type ketones. Mechanistic studies suggest that oxidative coupling of phenols and anilides shares a common pathway via homolytical heteroatom-hydrogen bond cleavage. Nitrosonium salt catalysis was applied for cross-dehydrogenative coupling initiated by generation of heteroatom-centered radicals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23042-75-3